De novo lipogenesis is an energy-expensive process whose role in adult mammals is poorly understood. We generated mice with liver-specific inactivation of fatty-acid synthase (FAS), a key lipogenic enzyme. On a zero-fat diet, FASKOL (FAS knockout in liver) mice developed hypoglycemia and fatty liver, which were reversed with dietary fat. These phenotypes were also observed after prolonged fasting, similarly to fasted PPAR␣-deficiency mice. Hypoglycemia, fatty liver, and defects in expression of PPAR␣ target genes in FASKOL mice were corrected with a PPAR␣ agonist. On either zero-fat or chow diet, FASKOL mice had low serum and hepatic cholesterol levels with elevated SREBP-2, decreased HMG-CoA reductase expression, and decreased cholesterol biosynthesis; these were also corrected with a PPAR␣ agonist. These results suggest that products of the FAS reaction regulate glucose, lipid, and cholesterol metabolism by serving as endogenous activators of distinct physiological pools of PPAR␣ in adult liver.
Introduction
liver when subjected to a prolonged fast (Kersten et al., 1999) . Fatty acids are thought to be the natural ligands for PPARα, but the precise origin of these activators is unknown. Primitive organisms exquisitely adapt gene expression to SREBPs (sterol regulatory element binding proteins) are anchanges in nutrients that are frequently accessible across a other class of proteins used by hepatocytes to coordinate carsingle biological membrane. Complex organisms must balance bohydrate and lipid metabolism (Horton et al., 2002) . They remetabolic supply and demand through physiological systems side in the ER and must be proteolytically cleaved in the Golgi ensuring appropriate provision of substrates to tissues without to yield forms that are transcriptionally active. There are two direct access to a nutrient source. In mammals, the liver intepredominant forms of SREBPs in animals, SREBP-1c, which grates nutrient intake and the delivery of carbohydrates and stimulates fatty-acid synthesis, and SREBP-2, which stimulipids to peripheral tissues. Hepatocytes, exposed to dietary lates cholesterol synthesis. Both are regulated by feeding/fastsignals (from portal blood flow) and systemic signals (from the ing. In particular, SREBP-1c participates in de novo lipogenesis arterial blood supply), coordinate gene expression and mainwhen dietary carbohydrates are abundant. SREBP-1c trantain homeostasis (Jump and Clarke, 1999; Langhans 2003) .
scription is affected by circulating levels of insulin and glucaAbnormal hepatocyte function is central to common human gon, critical hormones in glucose homeostasis, and the oxydiseases including type 2 diabetes (characterized by excessive sterol receptor LXR (Chen et al., 2004) . SREBP-2 transcription hepatic glucose production), atherosclerosis (associated with is affected by cholesterol availability. Fatty acids can affect excessive production of atherogenic lipoproteins by the liver), SREBP expression (Xu et al., 2002a; Pawar et al., 2003) . and steatohepatitis or fatty liver (commonly seen in obesity and Hepatic fatty acids for activating PPARα and altering SREBP insulin resistance).
expression can be derived from several sources. One simple Hepatocytes assimilate carbohydrate and lipid signals in part way to discriminate between sources is by classifying fat as through PPARα, a member of the nuclear receptor superfamily "new" or "old." Fatty acids synthesized from carbohydrates (Berger and Moller, 2002) . PPARs first appeared about 280 milrepresent new fat. Dietary fatty acids transported to the liver in lion years ago at the fish/mammal divergence (Latruffe and chylomicrons represent another source of new fat. New fat Vamecq, 2000) , providing a molecular mediator for adapting to might be retained in the liver (for storage, energy production, intermittent nutritional deprivation. PPARα stimulates the tranor the synthesis of structural and signaling lipids) or exported scription of genes critical for fatty-acid oxidation (Reddy, 2001) in VLDL to peripheral tissues for metabolism or storage. In the and ketogenesis (Rodriguez et al., 1994) . It also promotes gluappropriate milieu, stored or old fat is released from adipose coneogenesis through several mechanisms (Bernal-Mizrachi et tissue into the circulation. Those fatty acids not utilized for enal., Koo et al., 2004) , including the stimulation of hepatic ergy are returned to the liver where the ultimate fate of this old glycerol utilization (Patsouris et al., 2004) . Highlighting the imfat is poorly understood. Whether new and old fatty acids are portance of PPARα in managing energy stores, PPARα-defiinterchangeable or if fatty acids from certain sources are channeled to specific functions is unknown. cient mice develop hypoglycemia, hypoketonemia, and fatty To test the hypothesis that the metabolic fate of fatty acids mice were indistinguishable from their control littermates, nursed successfully, weaned normally, and were active and depends on their site of origin, we engineered mice with liverspecific inactivation of fatty-acid synthase, the enzyme catafertile. Rearrangement of the FAS gene was restricted to the liver in lyzing the first committed step in fatty-acid biosynthesis (Semenkovich, 1997) . FAS is a large multifunctional protein with FASKOL mice ( Figure 1B ). Southern blotting revealed a 7.3 kb native allele in DNA from control mice (W in Figure 1B ) carrying seven catalytic domains required to convert dietary carbohydrates into saturated fatty acids, mostly palmitate (C16:0).
the Cre transgene without the floxed FAS gene. Only the 8.9 kb floxed allele was detected in nonhepatocyte DNA from Germline FAS −/− mice die at the preimplantation stage, and even FAS +/− mice have increased fetal demise, indicating an FASKOL (F in Figure 1B ) mice. A 5.3 kb fragment, the predicted size following deletion of exons 4-8, was detected only in absolute requirement for FAS function during embryonic development (Chirala et al., 2003) . Unlike FAS −/− mice, FASKOL (for FASKOL (F) liver but not lung, heart, brain, kidney, or skeletal muscle. It was also absent from liver of mice carrying the FAS knockout in liver) animals are viable, allowing us to assess the impact of hepatic de novo lipogenesis on metabolism. Our floxed allele without Cre (F − in Figure 1B) . A less intense band at 8.9 kb, representing the floxed allele without rearrangement, results show that new but not old fat activates physiologically distinct pools of PPARα in liver to affect glucose, fatty-acid, was also present in DNA from FASKOL liver, reflecting nonhepatocytes in liver that would not be expected to transactivate and cholesterol homeostasis.
the albumin promoter to express Cre. Liver-specific rearrangement of the FAS gene in FASKOL mice was confirmed by PCR.
Results
A 317 bp product indicating deletion of exons 4-8 was seen only in liver in the presence of the floxed locus and Cre ( Figure  Generation Figure 1D ), adipose tissue, heart, and brain of FASKOL hepatic FAS enzyme activity, and plasma chemistries (data not shown), indicating that the loxP sites and NEO cassette did not mice. Since FAS synthesizes palmitate (C16:0) from malonyl-CoA, interfere with FAS expression.
Mice carrying the "silent" targeted allele were crossed with inactivation of FAS should increase malonyl-CoA and decrease palmitate. In overnight-fasted-12 hr chow-refed mice ( Figure 1D , animals expressing Cre recombinase driven by the adenovirus EIIa promoter (EIIaCre). EIIaCre-mediated recombination oclower panel), malonyl-CoA content was 3-fold higher (14.1 ± 3 nmol/g tissue) in FASKOL liver as compared to animals carrycurs early in development (2-8 cell stage) and at low levels, resulting in chimerism with selective deletion of the NEO casing the floxed allele without Cre (4.5 ± 2.3 nmol/g tissue). Levels were unaffected in other tissues of FASKOL mice (not sette in some animals. Analysis of DNA from offspring of lox + / wt × EIIaCre +/− matings documented the presence of all posshown). To evaluate metabolism under conditions known to be associated with induction of FAS activity, mice were fed a highsible deletion patterns. As expected, intercrossing mice carrying the floxed allele with the NEO cassette deleted yielded carbohydrate diet without fat (zero-fat diet or ZFD). The difference in hepatic malonyl-CoA persisted under these conditions: Mendelian proportions of each genotype, normal body and plasma characteristics, and normal hepatic FAS mRNA as well 11.0 ± 2.1 nmol/g in FASKOL versus 5.1 ± 1.6 nmol/g in controls. Without a dietary source of palmitate (ZFD), hepatic palas enzyme activity in each genotype (data not shown). The lox + /wt × EIIaCre cross also produced FAS-deficient alleles mitate content assayed by GC/MS using deuterated palmitic acid as internal standard was decreased in FASKOL mice (Fig-(heterozygotes with deletions of exons 4-8). FAS enzyme activity was decreased by w50% in tissues of heterozygotes, and ure 1E) as compared to control mice ("wt" or lox +/+ Cre − ) multiple intercrosses using these mice produced no homozygotes, confirming the embryonic lethality of complete FAS defiMetabolic characterization of FASKOL mice Although there were no phenotypic differences among the ciency (Chirala et al., 2003) .
FASKOL mice, with liver-specific inactivation of the FAS three different control mouse groups, all subsequent comparisons were made between FASKOL mice and lox +/+ Cre − (wt) gene, were produced by crossing lox + /wt mice with rat albumin promoter-Cre transgenic mice, which express Cre exclusively mice. On a normal chow diet, FASKOL mice had lower fasting insulin levels and a lower insulin/glucagon ratio compared to wt in postpartum liver (Postic and Magnuson, 2000 ) and FASKOL mice. Data are representative of two independent experiments with four mice per group. The molecular identities of these retention peaks were verified and quantitated by mass spectrometry. *, p < 0.05. remained low, but glucagon, the key hormonal defense against to ZFD-fed wt mice, and the livers were obviously pale in ZFDfed FASKOL mice (not shown), suggesting the presence of hehypoglycemia in mammals, increased by w50% (Table 1) . Consistent with stimulation of lipolysis in peripheral tissues by patic steatosis. glucagon, in ZFD-fed FASKOL mice, fat pad weight decreased, whole-body adiposity decreased, serum NEFA increased, and
Reversal of hypoglycemia and fatty liver in FASKOL mice liver weight increased in the setting of a modest increase in the transaminase ALT without affecting other liver function tests ZFD-fed FASKOL mice had distinct, reversible alterations in hepatic morphology. After 28 days of ZFD, FASKOL mice were hy- (Table 1) . Peripheral fat stores were depleted in ZFD-fed FASKOL mice, reflected by decreased leptin levels compared poglycemic (Figure 2A ), liver triglyceride content was increased ( Figure 2B ), and plasma ALT levels were modestly increased (Fig- with lower glucose levels at all time points in intraperitoneal (i.p.) glucose tolerance tests compared to ZFD-fed wt mice ure 2C). ZFD-induced hypoglycemia and ALT elevation in FASKOL mice resolved completely after reinstitution of chow ( Figure S1B , upper panel). Incorporation of the Wy compound into the ZFD tended to raise glucose levels in FASKOL mice diet for 17 days with values similar to those seen in control mice fed chow only. However, hepatic triglycerides remained relative to wt. However, there were no differences in insulintolerance tests between the genotypes with any of the dietary elevated albeit at significantly lower levels than on ZFD ( Figures  2A-2C ). Hepatic glycogen stores, determined by PAS staining, treatments ( Figure S1B , lower panel). Thirty minutes after i.p. glucose, FASKOL mice showed decreased glucose with insulin were decreased in ZFD-fed FASKOL mice ( Figure 2E , middle panel) compared to ZFD-fed wt mice ( Figure 2D , middle panel) levels similar to wt ( Figure S1C ). C peptide and insulin ratios were also similar between the genotypes on both chow and and replenished after reintroduction of chow ( Figure 2E , lower panel). Hepatic lipid content, determined by oil red O staining ZFD ( Figure S1D ). The hormonal response to ZFD-induced hypoglycemia in (ORO), mirrored the quantitative hepatic triglyceride determination-increased in ZFD-fed FASKOL mice ( Figure 2E , middle FASKOL mice was appropriate, with decreased insulin ( Figure  3B ) and increased glucagon ( Figure 3C ), yielding a low insulin/ panel) compared to ZFD-fed wt mice ( Figure 2D , middle panel) and significantly reduced after chow feeding ( Figure 2E , lower glucagon ratio ( Figure 3D ) compared to normoglycemic ZFDfed wt mice. The Wy compound fed with either chow or ZFD panel). As controls, liver sections from chow-only fed wt and FASKOL mice were also stained with PAS and ORO (Figures had no effect on insulin/glucagon ratios, although absolute insulin and glucagon levels were reduced in ZFD+Wy-fed wt and 2D and 2E, upper panel), and they showed no difference between the genotypes.
FASKOL mice ( Figures 3B-3C ). Hepatic glycogen depletion and triglyceride accumulation in Hypoglycemia and steatohepatitis are characteristic of PPARα deficiency. To determine if the metabolic derangements in ZFD-fed FASKOL mice were also prevented by the Wy compound. Lower glycogen content in ZFD-fed FASKOL mice (8.6 ± ZFD-fed FASKOL mice were related to defective activation of PPARα-dependent pathways, the potent PPARα activator 1.8 mol/g) compared to ZFD-fed wt mice (17.8 ± 4.1 mol/g) did not occur in ZFD+Wy-fed FASKOL mice nor in chow+ Wy14,643 was incorporated into both the chow and zero-fat diets. A time course of the effects of ZFD on fasting glucose is Wy-treated wt and FASKOL mice ( Figure 3E ). ZFD-fed FASKOL liver triglyceride content (14.1 ± 0.33 mg/g) was nearly twice shown in Figure S1A . Glucose tended to be lower by 3 days and plateaued at significantly lower levels between days 10 that of ZFD-fed wt livers (8.3 ± 0.28 mg/g) but not in the presence of dietary Wy compound ( Figure 3F ). No further reduction and 28. Consumption of the Wy compound with ZFD for 10 days significantly increased glucose levels in FASKOL mice in hepatic triglyceride content was noted in either wt or FASKOL mice treated with chow+Wy, compared to chow feedcompared to FASKOL mice eating the ZFD alone ( Figure 3A) . In contrast, addition of the Wy compound to chow diet for 10 ing alone. This quantitative analysis was confirmed histologically, as shown in Figures 3K and 3L . The marked steatosis days did not result in a significant change in glucose in either wt or FASKOL mice compared to chow diet alone ( Figure 3A) . noted in ZFD-fed FASKOL mice ( Figure 3L , 2 nd panel) did not occur in the presence of Wy compound ( Figure 3L, 4 th panel). ZFD-induced hypoglycemia in FASKOL mice was associated , white bars) and FASKOL (black bars) mice fed ZFD for 28 days (ZFD28d) and then switched to chow (ZFD28d/chow), or maintained only on chow for the duration of the study (Chow). Each bar represents the mean ± SEM of 4-5 mice of each genotype per group. p < 0.05 for the following: *, compared to the corresponding wt mice; #, compared to the corresponding chow-fed mice; **, compared to the corresponding 28 day ZFD-fed mice. D and E) Liver histology for wt (lox +/+ Cre − ) and FASKOL mice. After 28 days of ZFD feeding (middle panel), subgroups of the 16-to 20-week-old wt and FASKOL mice were switched to chow diet for 17 days (lower panel). As controls, four mice from each genotype were maintained only on chow diet for the duration of the study (upper panel). Sections from chow-only fed (chow), ZFD-fed (ZFD28d), and chow-switched (ZFD28d/chow) animals were stained with periodic acid schiff (PAS) or oil red O (ORO), magnification 10×. Vacuolation seen in 28 day ZFD-fed FASKOL mice (arrows) was mostly lipid as shown by ORO staining. Sections are representative of several animals for each condition.
Serum triglyceride and NEFA levels ( Figures 3G and 3H ) in both S2A). Glucose levels were unaffected by Wy feeding with either chow or ZFD. In contrast, C57BL/6 littermate control mice had wt and FASKOL mice were markedly decreased upon ingestion of Wy in both chow and ZFD, as expected. significantly higher glucose on chow that decreased after ZFD+Wy feeding ( Figure S2A ). Similarly, cholesterol levels were FASKOL mice on a chow diet had low levels of serum and hepatic cholesterol that were unaffected by ZFD feeding (Figunaffected in PPARα −/− mice regardless of diet and remained significantly higher than C57BL/6 control mice with both chow ures 3I and 3J). Both were increased in FASKOL mice when PPARα was activated using Wy14,643 in both the chow and and ZFD feeding ( Figure S2B ). Consistent with previous reports (Xu et al., 2002b) , fasting insulin levels in PPARα −/− mice ZFD ( Figures 3I and 3J ). In contrast, there were no significant effects on cholesterol levels in wt mice fed chow+Wy (Figures tended to be higher than in the C57BL/6 control mice under all dietary conditions (not shown). Also as expected in the 3I and 3J).
The reversal of hypoglycemia and hypocholesterolemia after PPARα −/− mice, NEFA levels were higher than in control mice, with no decrease in either NEFA or triglyceride levels after Wy ZFD+Wy feeding in FASKOL mice suggested that activation of PPARα-dependent pathways was involved. To determine if feeding, in contrast to control mice ( Figures S2C and S2D ). PPARα deficiency contributed to the phenotype, whole-body PPARα knockout (PPARα −/− ) mice were subjected to the same PPAR␣ activation and the expression of glucose metabolism genes dietary challenge described above. Despite having a lower fasting glucose on chow, PPARα −/− mice did not manifest any further To address the mechanisms by which ZFD-fed FASKOL mice manifest hypoglycemia and their subsequent restoration to decrease in glucose levels after 10 days of ZFD feeding (Figure normoglycemia with PPARα activation, we studied the expresInduction of gluconeogenic genes is regulated in part through PGC-1α, via PPARα-dependent induction of TRB3 sion of PPARα target genes critical for gluconeogenesis ( Figure  4 ). Messenger RNA levels for PPARα itself were unaffected in (Koo et al., 2004) . Expression of these genes was markedly changed in ZFD-fed FASKOL livers and responded to PPARα FASKOL mice on chow and ZFD in liver ( Figure 4A ), as well as in kidney and heart, two other tissues known to have high activation. PGC-1α expression was increased in ZFD-FASKOL livers ( Figure 4A ), likely due to elevated glucagon ( Figure 3C ), PPARα expression ( Figure S3A ). PPARα mRNA levels were appropriately induced after both chow+Wy and ZFD+Wy feeding and appropriately stimulated by Wy in both genotypes on ZFD, but only in the FASKOL mice on chow+Wy ( Figure 4A ). Expresin all tissues analyzed ( Figure 4A and Figure S3A ) since PPARα activation is known to stimulate its own transcription.
sion of TRB3, a recently identified PPARα target (Koo et al., Ser (αP-GSK3β), respectively. Middle panels represent the total Akt and GSK3β proteins detected after stripping and reprobing the membranes with pan-Akt (α-Akt) and GSK3β (α-GSK3β) antibodies, respectively. The gels were scanned and quantified by densitometry. Intensities of the phosphorylated and total protein bands of wt mice on chow diet (control, lane 1) was arbitrarily set at 100%, and the relative intensities of the other bands were expressed relative to the control. Each bar represents mean ± SEM for 3-4 male wt and FASKOL mice. p < 0.05 for the following: *, compared to the corresponding wt; #, compared to the corresponding chow-fed mice; **, compared to the corresponding ZFD-fed mice.
2004), and HNF4α, another transcription factor coactivated by Carbohydrate feeding is known to increase gluconeogenic flux (Bizeau et al., 2001) , explaining the increase in G6Pase, PGC-1α (Rhee et al., 2003) , were both suppressed in ZFD-fed FASKOL livers and were significantly induced by PPARα acti-PC, and PEPCK expression with the ZFD in wt mice. The failure of this response, in concert with suppressed hepatic HNF4α vation with Wy in both the chow and ZFD in FASKOL livers ( Figure 4A ). Recent data from Yamamoto et al. (2004) imply that despite a 3-fold induction of PGC-1α, provides a mechanism for the low glucose (Table 1 ; Figures 2A and 3A) in ZFD-fed HNF4α expression is regulated by the insulin/glucagon ratio as well, through crosstalk with SREBP-1c and its interference with FASKOL mice. Activation of PPARα with Wy in both chow and ZFD resulted in significant induction of G6Pase and PC above PGC-1α recruitment. HNF4α was shown to be absolutely required to induce gluconeogenic genes, as liver-specific HNF4α their respective baseline levels, but PEPCK was unaffected by Wy feeding ( Figure 4B ). This is consistent with previous reknockout mice had impaired induction of glucose 6-phosphatase (G6Pase) and phosphoenolpyruvate carboxykinase ports, showing that PEPCK is not a PPARα target in liver (Kersten et al., 1999) . Expression of FOXO1, another transcription (PEPCK) even when PGC-1α was maximally activated (Rhee et al., 2003) . Our results are consistent with these reports, with factor required for PGC-1α-mediated induction of gluconeogenic genes (Puigserver et al., 2003) , was also decreased in ZFDdecreased expression of the gluconeogenic genes G6Pase, pyruvate carboxylase (PC), and PEPCK in ZFD-fed FASKOL livers fed FASKOL mice but did not increase with Wy compound (not shown). (Figure 4B ).
Expression of glucokinase (GK) showed an appropriate ex-
It was induced >40-fold with ZFD feeding in FASKOL mice (Figure 5A ), which have high glucagon levels ( Figure 3C ). LPL is pression pattern ( Figure 4B ) consistent with the low-insulin/ high-glucagon hormonal milieu of the hypoglycemic ZFDalso known to be increased by PPARα ligands (Li et al., 2002) , and its expression was induced 7-to 10-fold with chow+Wy fed FASKOL mice. Carbohydrate feeding induces GK (Commerford et al., 2002) . This response was attenuated in ZFD-fed feeding and 40-to 45-fold with ZFD+Wy feeding in both wt and FASKOL mice ( Figure 5A ). In contrast, carnitine palmi-FASKOL mice since GK mRNA levels were identical to those of chow-fed mice ( Figure 4B ). Incorporation of Wy in either toyltransferase-1a (CPT-1a) was not affected in FASKOL livers under different feeding and ligand-treatment conditions (Figchow or ZFD decreased GK expression in FASKOL but not wt liver ( Figure 4B) . ure 5A). FASKOL mice had low levels of serum and hepatic cholesTo further define the mechanisms underlying ZFD-induced hypoglycemia in FASKOL mice, Akt/PKB and glycogen synterol that were unaffected by the absence of dietary fat, and these levels were increased by PPARα activation (Figures 3I thase kinase 3-β (GSK3β), regulators of glucose and glycogen metabolism respectively, were analyzed in wt and FASKOL and 3J). To determine if decreased hepatic cholesterol content in this model was due to decreased cholesterol synthesis, inmice. There were no effects in skeletal muscle (not shown). ZFD feeding in FASKOL mice increased hepatic 473 serinecreased excretion, or some combination of both, we analyzed the message levels for proteins mediating these processes. phosphorylated Akt ( Figure 4C , lane 4) and 9 serine-phosphorylated GSK3β ( Figure 4D , lane 4) compared to chow (lane 2, SREBP-2 expression was increased in FASKOL liver ( Figure  5B ), the expected response to diminished intracellular choles- Figures 4C and 4D) . Addition of Wy to chow and ZFD resulted in a marked decrease in the phosphorylated forms of Akt and terol levels (Sato et al., 1996) . SREBP-2 is induced when the intracellular sterol content is low, stimulating the expression of GSK3β to levels similar to those seen with chow-only feeding (compare lanes 6 and 8 to lane 2, Figures 4C and 4D ). These genes required for cholesterol synthesis. Despite the appropriate induction of SREBP-2, the expression of HMG-CoA reducdata suggest that enhanced hepatic insulin signaling in ZFDfed FASKOL mice leads to decreased expression of glucotase, a major SREBP-2 target gene and the rate-limiting enzyme in cholesterol synthesis, was decreased in both chow-and ZFDneogenic genes, ultimately causing hypoglycemia.
fed FASKOL mice ( Figure 5B ). The expression of insulin-induced gene 1 (Insig-1), which has been shown to inhibit cholesterol PPAR␣ activation and the expression of fatty-acid and cholesterol metabolism genes synthesis by blocking the proteolytic processing of SREBPs (Yang et al., 2002) and inducing proteosomal degradation of Similar to the striking changes in glucose-regulating genes, PPARα target genes critical for fatty-acid metabolism were de-HMG-CoA reductase (Sever et al., 2003) , was increased in chow-and ZFD-fed FASKOL livers compared to wt ( Figure 5B ). creased in ZFD-fed FASKOL livers ( Figure 5A ) and restored by pharmacological activation of PPARα. Expression of acyl-CoA Hepatic cholesterol synthesis, determined in vivo using tritiated water, was reduced by more than 50% in both chow-and ZFDoxidase (ACO), a peroxisomal fatty-acid oxidation enzyme and known PPARα target gene, was reduced by w50% in the livers fed FASKOL mice ( Figure 5C ). Treatment with the PPARα activator increased hepatic cholesterol biosynthesis by w2.5-fold, of ZFD-fed FASKOL mice ( Figure 5A ) but was unaffected in kidney and heart ( Figure S3B ). As expected, ACO expression markedly reduced Insig-1 expression ( Figure 5B ), increased HMG-CoA reductase expression ( Figure 5B ), increased hepatic was increased to the same level as wt in liver ( Figure 5A ) as well as in kidney and heart ( Figure S3B ) when the Wy comcholesterol content ( Figure 3J ), and appropriately decreased SREBP-2 expression ( Figure 5B ) in FASKOL mice. pound was combined with either the chow or ZFD. PPARα promotes ketone production. Expression of the mitochondrial enThe nuclear receptor LXRα and its target genes ABCG5 and ABCG8 are important regulators of cholesterol efflux (Repa et zyme HMG-CoA synthase-2 (HS-2), rate-limiting for hepatic ketogenesis and another known PPARα target gene, was deal., 2002) . Steady-state levels of mRNA for LXRα, ABCG5, and ABCG8 ( Figure 5B ), as well as ABCA1 (not shown) were unafcreased in ZFD-fed FASKOL mice and induced to the same level as wt when Wy was combined with ZFD but was almost fected in FASKOL mice and did not change with diet or Wy treatment. The mRNA levels of two apoproteins, apoB and 3-fold higher than wt with chow+Wy feeding ( Figure 5A ). The expression of liver fatty-acid binding protein (L-FABP), a apoE, involved in cholesterol export were also unaffected (not shown). Collectively, these data suggest that disruption of FAS, PPARα target shown to physically interact with PPARα (Wolfrum et al., 2001) , was reduced in ZFD-fed FASKOL livers, while regardless of dietary fat content, decreased hepatic cholesterol content by impairing cholesterol synthesis. it was increased in ZFD-fed wt livers compared to chow diet ( Figure 5A ). As expected for a PPARα target gene, it was induced with Wy feeding.
Prolonged fasting In FASKOL mice causes hypoglycemia, hepatic lipid accumulation, and decreased expression SREBP-1c expression was decreased in chow-and ZFD-fed FASKOL mice and was unaffected by Wy treatment compared of PPAR␣ target genes that are prevented by PPAR␣ activation to wt mice, consistent with the persistently low insulin levels in FASKOL mice ( Figure 3B ). SREBP-1c mRNA levels were unafTo confirm the observation that hepatic deficiency of FAS interferes with PPARα activation, we used a different model than fected by chow+Wy treatment but modestly decreased with ZFD+Wy feeding compared to ZFD alone ( Figure 5A ), likely re-ZFD feeding. Mice were subjected to a 24 hr fast ( Figure S4 ). FASKOL mice became hypoglycemic ( Figure S4A ), had deflecting the lower insulin in wt and FASKOL mice under these conditions ( Figure 3B) . creased serum levels of the ketone β-HBA ( Figure S4B ), and had elevated circulating NEFA ( Figure S4C ), effects that were Lipoprotein lipase (LPL), a gene not normally expressed at high levels in adult liver but known to be induced by glucagon reversed by i.p. administration of the PPARα activator at the initiation of the fast. Increased liver triglyceride content in 24 (Julve et al., 1996), was decreased in chow-fed FASKOL livers. , white bars) and FASKOL (black bars) mice fed chow, ZFD for 10 days (ZFD), chow+Wy14,643 for 10 days (C+Wy), and ZFD+Wy14,643 for 10 days (Z+Wy). Data are mean ± SEM of three independent RT-PCR experiments for each gene with four mice of each genotype per dietary treatment for each experiment. Data are presented relative to L32 ribosomal mRNA in the same samples and the relative mRNA levels were determined by QPCR using the comparative C T method. p < 0.05 for the following: *, compared to the corresponding wt; #, compared to the corresponding chow-fed mice; **, compared to the corresponding ZFD-fed mice. C) Hepatic cholesterol synthesis rates were determined in wt (white bars) and FASKOL (black bars) mice fed the various diets as described in (A) and (B) above using 3 H-water. Incorporation of 3 H-radioactivity into digitonin-precipitable sterols (DPS) was expressed as moles per hour per gram of tissue. Each bar represents the mean ± SEM of 3-5 male mice per genotype per dietary treatment. p < 0.05 for the following: *, compared to the corresponding wt; #, compared to the corresponding chow-fed mice; **, compared to the corresponding ZFD-fed mice.
hr fasted FASKOL mice was also prevented by Wy compound tially induced by Wy injection in the FASKOL mice, while PPARα expression was increased by Wy in both wt and ( Figure S4D ).
Gene expression in FASKOL mice subjected to the pro-FASKOL mice ( Figure S4E ). The expression of HNF4α in FASKOL livers after a 24 hr fast was similar to that seen in longed fast mirrored that of ZFD-fed animals. Although PPARα, PGC-1α, and TRB3 message levels were unaffected by geno-ZFD-fed FASKOL livers and was significantly induced by Wy ( Figure S4E ). The mRNA levels of cAMP response element type after a 24 hr fast, only the latter two genes were preferen-binding protein (CREB), regulated in the fasting state by glucanous PPARα activator. Even in the presence of dietary fat, gon, were higher in 24 hr fasted FASKOL mice with and without FASKOL mice tend to have lower glucose levels, insulin levels Wy injection, compared to wt ( Figure S4E ). CPT-1a was lower are significantly lower (Table 1) , and mRNA levels for the glucoin 24 hr fasted FASKOL livers ( Figure S4F ), different from the neogenic enzymes G6Pase and PC ( Figure 4B ) are significantly response in ZFD-fed FASKOL mice ( Figure 5A ), and unaffected induced, suggesting the need for increased gluconeogenesis by Wy administration. Expression of ACO, HS-2, PC, and (perhaps driven by dietary fat) in the absence of FAS. Over G6Pase (Figure S4F ), PPARα target genes involved in fatty-acid time, ZFD-fed FASKOL mice mobilize peripheral fat stores and oxidation, ketogenesis, and gluconeogenesis, was decreased transport this lipid to the liver where it accumulates (old fat in after a 24 hr fast in FASKOL mice, mirroring the expression Figure 6 ). But this lipid source fails to activate PPARα, blood patterns seen in ZFD-fed FASKOL mice, and all were induced glucose and cholesterol levels remain low, and steatohepatitis to wt levels when the PPARα activator was injected at the initiprogresses. Thus, specific fatty-acid pools synthesized by heation of the fast ( Figure S4F) .
patic FAS or derived from the diet, but not those stored in the liver after transfer from the periphery (even when present in Discussion abundance), activate PPARα to impact glucose and lipid metabolism. While these observations establish the existence of A model for differential effects of new versus distinct physiological lipid compartments, identification of the old fat in liver precise subcellular location of these compartments will require Fatty acids can serve as signaling molecules (Pegorier et al., additional studies. 2004) , especially in the liver, where perturbations of normal nutrient homeostasis in conditions such as insulin resistance, diabetes, and obesity result in the accelerated production of glu-FASKOL mice and the disruption cose and atherogenic lipoproteins, common contributors to of cholesterol metabolism human disease. In this paper, we show that the source of these Impaired activation of PPARα is a feasible cause of the hypofatty acids is critical for maintaining normal glucose, lipid, and glycemia/fatty-liver phenotype in our mice since this ligandcholesterol metabolism. activated transcription factor is known to play important roles When FASKOL mice (lacking the capacity to synthesize fatty in gluconeogenesis (Bernal-Mizrachi et al., 2003 ; Koo et al., acids from carbohydrate) were fed a diet without fat, they de-2004) , fatty-acid oxidation (Reddy, 2001) , and ketogenesis (Rodveloped hypoglycemia and fatty liver in the setting of deriguez et al., 1994) . FASKOL mice also had abnormal cholescreased expression of PPARα target genes (Table 1; Figures terol metabolism, characterized by decreased activation of a 2-5). The same effects were seen when FASKOL mice were critical SREBP-2 target gene (HMG-CoA reductase), that was subjected to prolonged fasting ( Figure S4 ), as in PPARα-deficorrected by treatment with a PPARα agonist. There is prececient mice. Malonyl-CoA participates in the regulation of fattydence for the involvement of PPARα and peroxisomes in choacid oxidation but is unlikely to mediate the FASKOL phenolesterol metabolism. Peroxisome-deficient PEX2 null mice have type since differences in malonyl-CoA were unaffected by diet a complex cholesterol phenotype (Kovacs et al., 2004) . Hepatic (Results). The hypoglycemia/steatohepatitis phenotype and cholesterol content is decreased, SREBP-2 mRNA is indefects in PPARα target gene expression were corrected by adcreased, SREBP-1c is decreased, and LXR target genes are ministration of a potent PPARα agonist (Figures 3-5 and Figure  not activated, effects also seen in FASKOL mice. In whole-S4). FASKOL mice also had a cholesterol phenotype that, unbody PPARα null mice, hepatic cholesterol and HMG-CoA relike the development of hypoglycemia/steatohepatitis, was not dependent on diet. Regardless of the availability of dietary fat, ductase expression are decreased (Patel et al., 2001) . PPARα serum and hepatic cholesterol levels were low in FASKOL mice activators have been reported to increase HMG-CoA reductase in association with increased SREBP-2, decreased HMG-CoA gene expression in hepatocytes (Le Jossic-Corcos et al., reductase gene expression, and decreased hepatic cholesterol 2004). Viewed together, these data suggest that normal peroxisynthesis (Figures 3 and 5) . These effects were also normalized somal function is required to maintain cholesterol homeostasis. by pharmacologically activating PPARα (Figures 3 and 5) . Thus, Cholesterol metabolism in FASKOL mice shares some feathe metabolic abnormalities in FASKOL mice appear to be tures with transgenic mice overexpressing Insig-1 in liver (Endriven by the failure to activate available PPARα. PPARα −/− gelking et al., 2004) and liver-specific HNF4α knockout mice mice did not develop a phenotype with ZFD feeding ( Figure S2) . (Hayhurst et al., 2001) . Insigs are ER proteins that, in the presOur results are consistent with the model shown in Figure 6 ence of sterols, bind to HMG-CoA reductase and SCAP, an indicating that new fatty acids are the endogenous activators escort protein required for the generation of transcriptionof physiologically distinct pools of PPARα. FASKOL mice are ally active SREBPs. Insig-1 liver transgenics have decreased protected from the hypoglycemia/steatohepatitis phenotype plasma and hepatic cholesterol, decreased activation of when new fat absorbed from the diet (D in Figure 6 ) is available SREBP-2 target genes such as HMG-CoA reductase, and no to activate one pool of PPARα and promote gluconeogenesis effect on LXR or its target genes, resembling FASKOL mice. (GNEO) as well as fatty-acid oxidation (FAO). Regardless of Liver-specific HNF4α knockout mice have decreased plasma diet, FASKOL mice have low hepatic stores of cholesterol that cholesterol, fatty liver, decreased expression of PPARα as well are normalized by PPARα activation, suggesting that new fat as L-FABP, and normal LXRα expression, as in FASKOL mice. produced by FAS (N in Figure 6 ) has access to a separate pool These data suggest that PPARα signaling through products of of PPARα capable of stimulating cholesterol biosynthesis the FAS reaction facilitates SREBP processing and HNF4α ac-(CHOL) in addition to gluconeogenesis and fatty-acid oxidation. New fat synthesized by FAS may be the preferred endogetivation. (Kliewer et al., 1997; Gottlicher et al., 1992) . with an affinity similar to that of some unsaturated fatty acids shown in Figure 1A . RW-4 embryonic stem cells were electroporated at the (Xu et al., 1999) . Physiologically, saturated fatty acids stimulate Washington University ES Core, and 5 of 191 screened colonies were found both gluconeogenesis (Bizeau et al., 2001 ) and cholesterol synto be correctly targeted. One clone (C12) was injected into C57BL/6 blastothesis (Glatz and Katan, 1993) , processes associated with cysts to generate chimeric mice. Floxed, germline offspring were crossed PPARα activation. HNF4α shows constitutive binding of satuwith albumin-Cre mice (Postic and Magnuson, 2000) or EIIaCre mice (Lakso rated as well as unsaturated C14-C18 fatty acids (Wisely et al., et al., 1996) . The Washington University Animal Care Committee approved 2002). It is thus plausible that FAS products could affect gene these experiments.
Mice were genotyped by PCR using FAS-specific primers (5#-ATGTCTGG expression by binding and activating PPARα.
TTGTTCTTGGGCTGA-3# and 5#-GGTCATCGAGACAACCACACAT-3#) and Cre-specific primers (5#-GCGGTCTGGCAGTAAAAACTATC-3# and 5#-GTG
How is new fat compartmentalized
AAACAGCATTGCTGTCACTT-3#). For Southern blotting, genomic DNA was to activate PPAR␣? isolated using DNAEasy Kit (Invitrogen), digested with NdeI and HindIII, and
The observation that new fat has specific metabolic effects detected using Probe C in Figure 1A .
implies the existence of discrete physiological compartments.
All experiments were performed at 16-20 weeks of age to allow for maxi-FAS is a cytosolic enzyme and PPARα, when it activates gene mal effects of albumin-Cre. Animals were fed a standard mouse chow diet expression, is in the nucleus. How is the product of a cytosolic (Purina 5053) with a total fat content of 4.5%, protein content of 22%, and enzyme delivered to a nuclear factor? How does the cell dis-45%-55% nitrogen-free excess (which includes carbohydrates) by weight, tinguish between newly absorbed and stored fat? One possiyielding a total caloric value of w3.0 kcal/g. The zero-fat diet (ZFD) (Harlan Teklad, TD 03314) consisted of 0% fat, 20% protein, and 63% carbohybility is that lipid binding proteins specific for new fat shuttle drates by weight, yielding a total caloric value of 3.3 kcal/g (24% protein/ fatty acids to nuclear PPARα. Liver fatty-acid binding protein 76% carbohydrate by caloric content). This diet is well tolerated in rodents (L-FABP) is present in both cytosol and nucleus and interacts (Iritani et al., 2000) . In some experiments, animals were fed either chow with PPARα (Wolfrum et al., 2001 (Spady and Dietschy, 1983) . Triglycerides, cholesterol, glucose, nonesterifed fatty acids (NEFA), and insulin were assayed as described (Marshall et al., 1999; Li et al., 2000) . Leptin and adiponectin were assayed by ELISA using commercial reagents Quantitative RT-PCR-based gene expression Total RNA was extracted with TRIzol reagent (Invitrogen). There was no (CrystalChem, R&D Systems). Glucagon and C peptide radioimmunoassays effect of genotype on RNA yields. After treatment with DNaseI, 1 g of total as well as determinations of ALT (alanine aminotransferase), bilirubin, alka-RNA was reverse transcribed with an oligo-dT primer, and then quantitative line phosphatase, albumin, lactate, and β-hydroxybutyrate were performed PCR was performed with the ABI Prism7700 PCR instrument (Applied Bioin mouse core facilities at Washington University. Body composition and systems) using the TaqMan Universal PCR Master Mix reagent kit. Each indirect calorimetry were performed as described (Bernal-Mizrachi et al., assay included a negative control using RNA not subjected to reverse tran-2002). Glucose-tolerance and insulin-tolerance tests were performed as description. Oligonucleotide primers and TaqMan probes were designed using scribed (Li et al., 2000) .
Primer Express software (Applied Biosystems). Sequences are shown in Table  S1 . Amplification specificity was verified by assessing products on an aga-FAS enzyme activity and malonyl-CoA content rose gel and using a heat-dissociation protocol. Sequence-specific amplifi-FAS enzyme activity was determined using a modification of a previously cation was detected with an increasing fluorescent signal of FAM (reporter described assay (Ullman and White, 1981) . Freshly harvested tissues were dye) during the amplification cycle. Coamplification of the mRNA for the weighed and homogenized in 0.1 M potassium phosphate buffer (pH 7.0), mouse ribosomal protein L32 was performed in all samples. Assays were containing 8% sucrose, 1 mM EDTA (pH 8.0), and 20 mM 2-mercaptoperformed in triplicate and results normalized to L32 mRNA levels, which ethanol at 4°C. Homogenates were centrifuged at 3,000 × g for 10 min at were unaffected by genotype or diet. Message levels were also normalized 4°C. Ten microliters of the supernatant was added to 80 l of assay buffer to another invariant internal control, acidic ribosomal phosphoprotein 36B4, (2 mM EDTA [pH 8.0], 2 mM DTT, 0.4 mg/ml NADPH), and the rate of with similar results to that seen with L32. NADPH oxidation was monitored at 340 nm. The substrate-dependent rate was determined by subtracting the NADPH oxidation rate from the rate after Western blotting adding 10 l of 0.85 mg/ml of malonyl-CoA (Sigma).
Livers and skeletal muscle (gastrocnemius) were frozen and homogenized Malonyl-CoA was determined in extracts homogenized in deionized at 4°C as described previously (Kerouz et al., 1997) . Thirty micrograms of water. CoA esters were separated using reversed-phase HPLC on a 5 m protein were resolved on a 10% SDS-polyacrylamide gel, electrotransferred Supelco C18 column with a Waters HPLC system, monitoring 254 nm as onto PVDF membranes (Amersham). Membranes were incubated with rabthe maximal absorbance for CoA. Buffers, gradients, and flow rates were bit anti-mouse phospho-Akt (recognizing phosphorylated Akt at serine 473, those described previously (Pizer et al., 2000) .
Cell Signaling 9271) and rabbit anti-mouse phospho-GSK3β (recognizing phosphorylated GSK3b at serine 9, Cell signaling 9336) at 1:1000 dilution Gas chromatography-mass spectrometry (GC-MS) at 4°C overnight, followed by secondary antibody incubation at 1:7500 diluSamples were analyzed as described (Turk et al., 1986; Wolf et al., 1991) .
tion for 1 hr. Phospho-Akt-and phospho-GSK3β-specific bands were deFifty milligram aliquots of frozen liver were homogenized in 3 ml of 2:1 (v/v) tected by chemiluminescence (ECL kit, Amersham), then membranes were chloroform:methanol and the organic phase isolated. Thirty microliters of stripped and reprobed with rabbit anti-mouse pan-Akt (recognizing total Akt each extract was saponified in 1.0 ml of 5 mM KOH in ethanol for 2 hr at protein, Cell Signaling 9272) and rabbit anti-mouse pan-GSK3β (recognizing 100°C followed by treatment with 100 l 1.2 N HCl and 2.5 ml of ethyl total GSK3β protein, Cell Signaling 9332) also at 1:1000 dilution at 4°C acetate. The organic phase was derivatized to methyl esters by the addition overnight. Reprobing with anti-actin antibody (Sigma, A2066) was perof 100 l HCl:methanol (1:3 v/v) and heating at 70°C for 1 hr. The derivatized formed to ensure equal loading of protein in all lanes. samples were reconstituted in hexane and analyzed on a Varian 3400 gas chromatograph interfaced to a Finnegan SSQ 7000 mass spectrometer.
Statistical analyses Samples were analyzed at injector and transfer line temperatures of 250°C
Values are expressed as mean ± standard error of the mean (SEM). Statistiand ionization was achieved by electron impact. Selected ion monitoring cal comparisons were performed using an unpaired, two-tailed Student's t was used at mass-to-charge ratio (m/z) of 270 and 274 for the methyl esters test (when two groups were analyzed) or analysis of variance (ANOVA). If of native palmitate and of the 5,5,6,6-palmitic acid-d4 internal standard, the overall F was found to be significant for the latter, comparisons between respectively. The ratio of the ion current at m/z 270 and 274 was used to means were made using appropriate post-hoc tests. determine the amount of palmitate by interpolation from a standard curve.
Hepatic assays and histology
Supplemental data Frozen aliquots (25-30 mg) of liver were homogenized in chloroform:methaSupplemental data include four figures and one table and can be found nol (2:1 vol/vol) and extracts analyzed using ThermoDMA triglyceride and with this article online at http://www.cellmetabolism.org/cgi/content/full/1/ cholesterol reagents (Thermoelectron Corp.). Perchloric acid extracts of 5/309/DC1/. liver were assayed for glycogen by the amyloglucosidase method (Passonneau and Lauderdale, 1974) . For histology, some livers were fixed in 10% neutral buffered formalin and embedded in paraffin, and 4-6 m sections
